Genome Med. 2010 Jul 29;2(7):45.

Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers?

Source

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Bos 281, 171 77 Stockholm, Sweden. ross.hopkins@biomedcentral.com.

Abstract

Prostate cancer is one of the most heritable cancers in men, and recent genome-wide association studies have revealed numerous genetic variants associated with disease. The risk variants identified using case-control designs that compared unaffected individuals with all types of patients with prostate cancer show little or no ability to discriminate between indolent and fatal forms of this disease. This suggests different genetic components are involved in the initiation as compared with the prognosis of prostate cancer. Future studies contrasting patients with more and less aggressive disease, and exploring association with disease progression and prognosis, should be more effective in detecting genetic risk factors for prostate cancer outcome.

PMID:: 20667146; [PubMed]
PMCID:: PMC2923737

Free PMC Article

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Final Report on Carcinogens Background Document for Formaldehyde. [Rep Carcinog Backgr Doc. 2010]
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program. Rep Carcinog Backgr Doc. 2010 Jan; (10-5981):i-512.
Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer. [Cancer Epidemiol Biomarkers Pr...]
Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, Feng Z, Ostrander EA, Stanford JL. Cancer Epidemiol Biomarkers Prev. 2011 Jun; 20(6):1196-203. Epub 2011 Apr 5.
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. [J Natl Cancer Inst. 2007]
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, et al. J Natl Cancer Inst. 2007 Dec 19; 99(24):1836-44. Epub 2007 Dec 11.
Review DNA methylation changes in prostate cancer: current developments and future clinical implementation. [Expert Rev Mol Diagn. 2009]
Review DNA methylation changes in prostate cancer: current developments and future clinical implementation.
Hoque MO. Expert Rev Mol Diagn. 2009 Apr; 9(3):243-57.
Review Prostate cancer genomics: towards a new understanding. [Nat Rev Genet. 2009]
Review Prostate cancer genomics: towards a new understanding.
Witte JS. Nat Rev Genet. 2009 Feb; 10(2):77-82. Epub 2008 Dec 23.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

Prostate cancer genomics: can we distinguish between indolent and fatal disease ...
Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers?
Genome Med. 2010 Jul 29 ;2(7):45.

PubMed
A population-based study of bronchial asthma in adult twin pairs.
A population-based study of bronchial asthma in adult twin pairs.
Chest. 1991 Jul ;100(1):70-5.

PubMed
TIF1gamma controls erythroid cell fate by regulating transcription elongation.
TIF1gamma controls erythroid cell fate by regulating transcription elongation.
Cell. 2010 Jul 9 ;142(1):133-43.

PubMed
On estimating HLA/disease association with application to a study of aplastic an...
On estimating HLA/disease association with application to a study of aplastic anemia.
Biometrics. 1991 Mar ;47(1):53-61.

PubMed
Applications of array comparative genomic hybridization in obstetrics.
Applications of array comparative genomic hybridization in obstetrics.
Obstet Gynecol Clin North Am. 2010 Mar ;37(1):71-85, Table of Contents.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers?

Source

Abstract

LinkOut - more resources

Full Text Sources

Other Literature Sources

Libraries

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information